These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23150076)

  • 1. Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats.
    Gerbeth K; Hüsch J; Meins J; Rossi A; Sautebin L; Wiechmann K; Werz O; Skarke C; Barrett JS; Schubert-Zsilavecz M; Abdel-Tawab M
    Planta Med; 2012 Dec; 78(18):1932-8. PubMed ID: 23150076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of myrtucommulone from Myrtus communis in human and rat plasma by liquid chromatography/tandem mass spectrometry.
    Gerbeth K; Meins J; Werz O; Schubert-Zsilavecz M; Abdel-Tawab M
    Planta Med; 2011 Mar; 77(5):450-4. PubMed ID: 21049398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Pollastro F; Northoff H; Werz O
    Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo.
    Rossi A; Di Paola R; Mazzon E; Genovese T; Caminiti R; Bramanti P; Pergola C; Koeberle A; Werz O; Sautebin L; Cuzzocrea S
    J Pharmacol Exp Ther; 2009 Apr; 329(1):76-86. PubMed ID: 19056932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase.
    Wiechmann K; Müller H; Huch V; Hartmann D; Werz O; Jauch J
    Eur J Med Chem; 2015 Aug; 101():133-49. PubMed ID: 26123643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic phloroglucinols from the leaves of Myrtus communis.
    Cottiglia F; Casu L; Leonti M; Caboni P; Floris C; Busonera B; Farci P; Ouhtit A; Sanna G
    J Nat Prod; 2012 Feb; 75(2):225-9. PubMed ID: 22276775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Metabolic Stability and Permeability of Gymnemagenin and Its In Vivo Pharmacokinetic Correlation in Rats - A Pilot Study.
    Bera R; Kundu A; Sen T; Adhikari D; Karmakar S
    Planta Med; 2016 Apr; 82(6):544-50. PubMed ID: 26916641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and antibacterial activity of acylphloroglucinols from Myrtus communis.
    Rotstein A; Lifshitz A; Kashman Y
    Antimicrob Agents Chemother; 1974 Nov; 6(5):539-42. PubMed ID: 15825301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoisomeric Composition of Natural Myrtucommulone A.
    Hans M; Charpentier M; Huch V; Jauch J; Bruhn T; Bringmann G; Quandt D
    J Nat Prod; 2015 Oct; 78(10):2381-9. PubMed ID: 26457652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phloroglucinol Derivatives from Myrtus communis 'Variegata' and Their Antibacterial Activities.
    Wu Y; Chen M; Wang WJ; Li NP; Ye WC; Wang L
    Chem Biodivers; 2020 Aug; 17(8):e2000292. PubMed ID: 32539173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
    Hieke M; Greiner C; Dittrich M; Reisen F; Schneider G; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2011 Jul; 54(13):4490-507. PubMed ID: 21591611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
    Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meroterpenoids with New Skeletons from Myrtus communis and Structure Revision of Myrtucommulone K.
    Liu C; Ang S; Huang XJ; Tian HY; Deng YY; Zhang DM; Wang Y; Ye WC; Wang L
    Org Lett; 2016 Aug; 18(16):4004-7. PubMed ID: 27471772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.
    Elkady M; Nieß R; Schaible AM; Bauer J; Luderer S; Ambrosi G; Werz O; Laufer SA
    J Med Chem; 2012 Oct; 55(20):8958-62. PubMed ID: 22992107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
    De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
    J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of myrtucommulone A.
    Müller H; Paul M; Hartmann D; Huch V; Blaesius D; Koeberle A; Werz O; Jauch J
    Angew Chem Int Ed Engl; 2010 Mar; 49(11):2045-9. PubMed ID: 20155764
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamic modeling of human 5-lipoxygenase-inhibitor interactions helps to discover novel inhibitors.
    Wu Y; He C; Gao Y; He S; Liu Y; Lai L
    J Med Chem; 2012 Mar; 55(6):2597-605. PubMed ID: 22380511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol.
    Koeberle A; Northoff H; Werz O
    Biochem Pharmacol; 2009 May; 77(9):1513-21. PubMed ID: 19426689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.